Melanoma onset and progression involves alterations in signaling pathways, including mitogen-activated protein kinase (MAPK), protein kinase B (AKT) and p53 pathways [95], which affect processes such as cell-cycle regulation, pigmentation, as well as others. This evidence concerns the gene AKT1 and melanoma.